Where does Personalis, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Personalis, Inc. ranks #8,460 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Personalis, Inc. hold?

Personalis, Inc. holds 38 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Personalis, Inc.'s Innovation Score?

Personalis, Inc. has an Innovation Score of 53.6 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Personalis, Inc.'s patent grant rate increasing or decreasing?

Personalis, Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Personalis, Inc.'s patents?

Personalis, Inc.'s patents average 23.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Personalis, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Personalis, Inc.

Q: What technology areas does Personalis, Inc. focus on?

Personalis, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 35 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 38 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Personalis ranks #8,460 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 10 technology areas.

#8,460
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.6/100): 23.3
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8460 · US Corporation #8,460 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,460/49,997
PHOTO-FINISH OsteoMed
CPC-FOCUS C12Q · 10 areas
INNOV-PAR 53.6/100
CLAIMS-DENSE 23.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: OsteoMed LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Freeport Minerals · near

54
MerchSource · near

54
Miba Gleitlager… · near

54
National Applied… · near

54
Personalis · this assignee

54
3D Lighting… · lowest

7

What this shows Personalis's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Personalis's grants concentrate

Personalis, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 92.1% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (9 grants) versus a trough of 1 in 2020. By volume, Personalis sits between OsteoMed LLC and ProSports Technologies, LLC.

Personalis's three-year grant acceleration

Personalis, Inc. shows 19 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Osteomed

38
Parata Systems

38
Packers Plus Ener…

38
Palodex Group Oy

38
Platform Science

38
Primal Fusion

38
Printpack Illinois

38
Prosports

38
Personalis ◀

38

What this shows Personalis holds 38 patents at rank #8,460, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Personalis

By rank, the assignees closest to #8,460 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Personalis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Personalis, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Miba Gleitlager Austria GmbH 54 Freeport Minerals Corporation 54 National Applied Research Laboratories 54 MerchSource, LLC 54

Personalis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Personalis, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.3%
2017	2	5.3%
2018	2	5.3%
2019	5	13.2%
2020	1	2.6%
2021	2	5.3%
2022	5	13.2%
2023	9	23.7%
2024	5	13.2%
2025partial year	5	13.2%

Which technologies does Personalis, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 35

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 34

Y02A - Technologies FOR Adaptation TO Climate Change 21

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

G06N - Computing Arrangements Based ON Specific Computational Models 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

G06F - Electric Digital Data Processing 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#8,460

of 49,997 tracked assignees

Innovation Score

53.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Personalis, Inc.'s patent record in context - here's where to go next.

Personalis, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 92.1% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #8,460 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Personalis, Inc. against OsteoMed LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.